Combined Treatment with Autologous CIK Cells, Radiotherapy and Chemotherapy in Advanced Cervical Cancer
- 46 Downloads
To investigate the clinical efficacy of autologous cytokine induced killer (CIK) cells transfusion combined with radiochemotherapy in the treatment of advanced cervical cancer. A total of 89 hospitalized patients with advanced cervical cancer were admitted and divided into the treatment group (44 cases, autologous CIK cells transfusion combined with radiochemotherapy) and the control group (45 cases, radiochemotherapy) by a randomized non-blind method. Comparisons of therapeutic efficacies, immune functions, life qualities and survival rates were analyzed between the two groups. The short-term therapeutic efficacy of the treatment group was significantly higher than that of the control group. There was no significant difference in 1, 2 and 3 year survival rates between the two groups. Compared with pre-treatment, levels of CD3+, CD4+/CD8+ in peripheral blood were increased in the CIK group, which were reduced in the control group. In the CIK group,only the feeling was depressed on the 25th day post-treatment (T25) compared with the day before treatment (B1). However in the control group, the function of body, role, social and holistic health was obvious disordered on day T25 compared with day B1. On day T25, there were significant differences in function of body, social and holistic health between two groups. Autologous CIK cells transfusion combined with radiochemotherapy shows better short-term efficacy than radiochemotherapy alone in the treatment of advanced cervical cancer, which obviously improves immune function and life quality of patients with low side effects.
KeywordsAutologous CIK cell Advanced cervical cancer Radiochemotherapy
This study was supported by the Science and Technology Research Projects of Kaifeng City.
Compliance with Ethical Standards
Conflict of Interest
The authors report no potential conflict of interest.
- 1.Hu Y, Sun X, Mao C, et al (2017) Upregulation of long noncoding RNA TUG1 promotes cervical cancer cell proliferation and migration. Cancer Med 6(2):471–482Google Scholar
- 2.Artan, I.M., et al., The knowledge, attitude and behavioral-intent regarding cervical cancer and the human papillomavirus (HPV) vaccine: A cross-sectional study among female university students in Ajman, UAEGoogle Scholar
- 3.Ferlay J et al (2010) Cancer incidence and mortality worldwide: IARC CancerBase no.11. IARC 136(5):E359–E386Google Scholar
- 7.Niam M, Linn YC, Fook Chong S, Lim TJ, Chu S, Choong A, Yong HX, Suck G, Chan M, Koh M (2011) Clinical scale expansion of cytokine-induced killer cells is feasible from healthy donors and patients with acute and chronic myeloid leukemia at various stages of therapy. Exp Hematol 39(9):897–903.e1CrossRefGoogle Scholar
- 9.Liu AM et al (2011) Antitumor effects of cytokine- induced killer cells on cervical cancer HeLa cells in vitro and in vivo. Carcino, Terato & Muta 23(5):353–161Google Scholar
- 13.Mesiano G, Todorovic M, Gammaitoni L, Leuci V, Giraudo Diego L, Carnevale-Schianca F, Fagioli F, Piacibello W, Aglietta M, Sangiolo D (2012) Cytokine-induced killer (CIK) cells as feasible and effective adoptive immunotherapy for the treatment of solid tumors. Expert Opin Biol Ther 12(6):673–684CrossRefGoogle Scholar
- 14.Jonathan Benjamin M (2013) Early infusion of donor-derived CIK cells as consolidative immunotherapy following non-Myeloablative allogeneic transplantation: safety and feasibility. Blood 122Google Scholar
- 15.Linn YC, Yong HX, Niam M, Lim TJ, Chu S, Choong A, Chuah C, Goh YT, Hwang W, Loh Y, Ng HJ, Suck G, Chan M, Koh M (2012) A phase I/II clinical trial of autologous cytokine-induced killer cells as adjuvant immunotherapy for acute and chronic myeloid leukemia in clinical remission. Cytotherapy 14(7):851–859CrossRefGoogle Scholar
- 16.Geng J, Zhang Q, Tong J (2016) Effect of chemoradiation combined with DC-CIK cells biological therapy on the treatment of patients with middle-advanced non-small cell lung cancer. J Clin Med in Prac 20(9):48–50Google Scholar
- 17.Shi L et al (2012) Adjuvant immunotherapy with CIK cells for stage III gastric Cancer. J Basic Clin Onco 25(3):62–65Google Scholar
- 18.Luo X et al (2016) Curative effect of autologous DC-CIK cells on metastatic renal cell carcinoma. J Mod Oncol 15:2426–2429Google Scholar